NBIX: Neurocrine Biosciences, Inc. Company Cash Volume

NBIX (Neurocrine Biosciences, Inc.) - company brandmark

Neurocrine Biosciences (NBIX) relies on a biopharmaceutical leverage model where costly research is offset by future monopolies. This cash flow chart demonstrates liquidity stability, and 0.74 shows the value of this parameter. Business security is guaranteed by the neutrality of medicine in geopolitics. High scalability is ensured by the minimal synthesis cost of proprietary drugs against colossal revenue volumes.

Company Cash Reserve: Neurocrine Biosciences Inc (NBIX) for 07/04/2022 - 11/21/2026

Metric breakdowns and analytics for Neurocrine Biosciences, Inc. (NBIX)

Basic company analysis:Neurocrine
Brand item of neurocrine.com

For the biopharmaceutical sector, Neurocrine Biosciences (NBIX) cash balance changes reflect the company's ability to fund costly scientific research and development. This metric captures the volume of immediately available liquid assets, excluding illiquid assets. The trend is driven by the difference between capital inflows and expenditures on R&D, grants, and neurobiologist payroll. A stable cash reserve confirms financial stability and guarantees the uninterrupted execution of the mission to create new medicines.

Competitors of Neurocrine Biosciences (NBIX)

Company Cash Volume BIIB|RGC - Company Cash Reserve|Company Cash Funds Axsome Therapeutics AXSM|Company Cash Volume ACADIA Pharmaceuticals Inc. ACAD|xenon-pharma.com - Company Cash Volume|Company Cash Reserve Viking Therapeutics|SUPN: Company Cash Volume|Catalyst Pharmaceuticals (CPRX) - Company Cash Volume|Company Cash on Hand DNLI|Company Cash and Cash Equivalents HRMY (Harmony Biosciences Holdings, Inc.)|Company Cash Funds Biohaven Ltd. (BHVN)|Company Total Cash Amount AMLX|Company Cash Funds trevitherapeutics.com TRVI|PRAX - Company Cash on Hand|Anavex Life Sciences Corp - Company Cash Volume|Company Cash Reserve CeriBell Corp|Prothena Corporation PLC (PRTA) - Company Cash Funds|Alector Therapeutics - Company Cash Balance|Company Cash Funds Annexon Biosciences|Company Cash Reserve omeros.com OMER|Company Cash Funds Neurogene (NGNE)|Company Liquid Assets AC Immune S.A.|Company Cash Volume VYGR (Voyager Therapeutics Inc)|Company Cash Balance NMRA|scilexholding.com - Company Cash Volume|TVGN (tevogen.com) - Company Cash and Cash Equivalents|ACOG: Company Cash Volume|CGTX: Company Total Cash Amount|Company Cash Funds Inhibikase Therapeutics|Company Cash and Cash Equivalents SAVA (Cassava)|Company Cash Funds Assertio Therapeutics (ASRT)|Coya Therapeutics - Company Cash and Cash Equivalents|VistaGen Therapeutics, Inc. - Company Cash on Hand|ovidrx.com (OVID) - Company Cash Reserve|ABOS: Company Cash on Hand|Company Cash Reserve CervoMed Inc|alteritytherapeutics.com (ATHE) - Company Cash Funds|Company Cash on Hand Clene Nanomedicine|Company Cash on Hand PEPG|Company Cash Reserve Jupiter Neurosciences JUNS|Company Cash Funds Relmada (RLMD)|Company Liquid Assets Annovis Bio, Inc.|Company Cash Volume GRCE (Grace Tx)|Firefly Neuroscience, Inc (AIFF) - Company Cash Reserve|KLTO - Company Cash Funds|Company Cash Reserve NeuroSense Therapeutics Ltd|RVPH: Company Cash Volume|MetaVia, Inc. (MTVA) - Company Cash Volume|Company Cash Funds NeurAxis|Company Cash Volume heliusmedical.com|Company Cash on Hand PASG (Passage Bio Inc.)|Neuphoria Therapeutics - Company Cash and Cash Equivalents|Minerva Neurosciences Corp - Company Cash on Hand|Company Cash Balance ATHA|ADXN - Company Cash Funds|Company Cash Reserve Alzamend Neuro Inc.|Cyclerion Therapeutics (CYCN) - Company Cash Funds|Company Cash and Cash Equivalents PTIX|KTTA (pasitheaclinics.com) - Company Cash Volume|CRGT (cortigent.com) - Company Total Cash Amount|Company Cash Volume ATXI|Company Cash Funds BCLI (Brainstorm Cell)|Company Cash Volume CARA (Cara Therapeutics Inc)|Company Cash Balance CHRO|Eliem Therapeutics Inc. - Company Cash Volume|ITCI - Company Cash Volume|Longboard Pharma (LBPH) - Company Cash Funds|Company Cash on Hand Marinus Pharmaceuticals|Company Cash Funds NKGen|Company Cash Volume NeuroBo Pharmaceuticals, Inc.|Company Cash Volume SAGE|Synaptogenix, Inc - Company Cash and Cash Equivalents|Company Cash Funds Trevena TRVN|Company Cash Position Vigil Neuroscience|Anew Medical Inc. - Company Cash Volume|Company Liquid Assets Cerevel Therapeutics, Inc. CERE